SCHEMBL45614

SCHEMBL45614

C/C(=C\[S+](C)[O-])c1cc2c(o1)C(=O)c1ccccc1C2=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 6/20 0.62
ALDH1A1 P00352 5/20 0.62
MAPT P10636 6/20 0.36
HTT P42858 3/20 0.36
LMNA P02545 3/20 0.36
MITF O75030 1/20 0.36
KMT2A Q03164 6/20 0.33
MEN1 O00255 5/20 0.33
RAB9A P51151 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
BCL2 P10415 1/20 0.33
MCL1 Q07820 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
APAF1 O14727 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
MAOA P21397 1/20 0.33
MAPK1 P28482 1/20 0.33
CDC25B P30305 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45742 0.86 STAT3 (0.58) STAT3ALDH1A1MAPTHTTLMNA
Napabucasin SCHEMBL1883845 0.78 STAT3 (1.00) STAT3ALDH1A1MAPTHTTLMNA
Napabucasin SCHEMBL29349770 0.78 STAT3 (1.00) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL16917433 0.75 STAT3 (0.76) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL18730820 0.74 STAT3 (0.69) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL45638 0.72 ALDH1A1 (0.53) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL12640087 0.71 STAT3 (0.75) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL12494612 0.71 STAT3 (0.73) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL12640086 0.70 STAT3 (0.73) STAT3ALDH1A1MAPTHTTLMNA
SCHEMBL18691843 0.70 STAT3 (0.73) STAT3ALDH1A1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 US disclosed
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 US disclosed
WO-2012024818-A1 NOVEL ANPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES NQO1, NME2, CYP27B1 STAT3 1764/4885ALDH1A1 282/4885MAPT 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.